PROGENRA, INC
610-644-6974 x319
271 Great Valley Pkwy Ste 300
Malvern, Pennsylvania
19355-1308
, USA
Fax: 610-644-8616
Website Links: PROGENRA, INC | Business Models | Corporate Overview | Disease Focus | Drug Targets | DUB Technology Platform | Executive Summary | Job Openings | Ligase Technology Platform | Meeting Presentations | News & Media | Nicholson et al., 2007] | Our Approach | Our Culture | Our Mission | Partnership | Pipeline | Progenra contributes... | Progenra Fact Sheet | Progenra in the News
progenra inc. is a biotechnology company committed to developing research tools for drug discovery. our focus is the rapidly expanding field of protein degradation in the cell (exemplified by ubiquitin pathway enzymes). through our expertise in this area we are developing strategies to find novel treatments for major medical conditions such as parkinson's disease, cancer, myopathy, arthritis, and osteoporosis.
Products & Services
| Year Established | 2002 |
| Annual Sales | Below US$1 Million |
| Business Type | Manufacturer,Service |
Web Site Results
- Our Approach
...targeting the ubiquitin-proteasome pathway. The drug
- News & Media Publications Progenra
- ...novel inhibitors of deubiquitinating enzymes Seth J Goldenberg,
- Progenra contributes...
- ...diseases. The ubiquitin-proteasome system plays important
- Disease Focus
- ...of the ubiquitin-proteasome pathway can affect
- Drug Targets
...degraded in the proteasome, or relocated from